Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients;Bioäquivalenz von L-thyroxin-tabletten und L-thyroxin-tropfen bei der behandlung der hypothyreose in der täglichen praxis

Medizinische Klinik

Volumn 99, Issue 11, 2004, Pages 639-644

  Grussendorf, Martin ^a,d   Vaupel, Renate ^b   Wegscheider, Karl ^c  

^a Endokrinologie und Diabetologie Im Zentrum   (Germany)

^b Division Henning   (Germany)

^c Biometrie und Statistik GmbH   (Germany)

^d Innere Medizin/Endokrinologie   (Germany)

Author keywords

Bioavailability; Bioequivalence; Hypothyroidism; Levothyroxine; T4 solution; T4 substitution; Thyrotropin

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; RADIOACTIVE IODINE; THYROTROPIN;

ADULT; AGE DISTRIBUTION; ALLERGY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; HUMAN; HYPOTHYROIDISM; INFANT; LIQUID; SIDE EFFECT; SWALLOWING; TABLET; TIME SERIES ANALYSIS; TITRIMETRY;

ADOLESCENT; ADULT; AGED; CHILD; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SOLUTIONS; TABLETS; THERAPEUTIC EQUIVALENCY; THYROTROPIN; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE;

EID: 11244267390     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-004-1096-4     Document Type: Article

References (20)

1. Toft AD. Thyroxine therapy. N Engl J Med 1994;331:174-80.
2. Toft AD. Thyroid hormone replacement - one hormone or two? [Editorial]. N Engl J Med 1999;340:468-70.
3. Gharib H, Mazzaferri E. Throxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998;128:386-94.
4. Deutsche Gesellschaft für Chirurgie. Leitlinien zur Therapie der benignen Struma. Grundlagen der Chirurgie G 80. Beilage zu: Mittlg Dtsch Ges Chir 1998;27.
5. Feldkamp J, Seppel T, Mühlmeyer M, et al. Therapie der endemischen Struma mit Jodid oder L-Thyroxin bei älteren Patienten. Dtsch Med Wochenschr 1996;121:1587-91.
6. Reuss ML, Paneth N, Pinto-Martin JA, et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996;334:821-7.
7. Rovet J, Ehrlich R. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1995;126:380-6.
8. Touati G, Leger J, Toublanc J, et al. A thyroxine dosage of 8 micrograms/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism. Eur J Pediatr 1997;156:94-8.
9. Van Wassenaer AG, Kok JH, de Vijlder JJM, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997;336:21-6.
10. Briet JM, van Wassenaer AG, Dekker FW, et al. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001;107:712-8.
11. Heppe JH, Krude H, L'Allemand D, et al. The use of L-T4 as liquid solution improves the practicability and individualized dosage in newborns and infants with congenital hypothyroidism. J Pediatr Endocrinol Metab 2004;17:967-74.
12. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Postgrad Med 2002;48:206-8.
13. Committee for Proprietary Medicinal Products. Note for guidance on the investigation of bioavailability and bioequivalence (CPMP/EWP/ QWP/1401/98 DRAFT). London: Committee for Proprietary Medicinal Products, 1998.
14. Chassard D, Kerihuel J, Caplain H, et al. Comparative bioequivalence study of a new levothyroxine solution versus a reference L-thyroxine solution in normal healthy volunteers. Eur J Drug Metab Pharmacokinet 1991;Spec No 3:324-6.
15. Förster G, Hansen C, Mörsch F, et al. Bioäquivalenz eines Kombinationspräparates aus Levothyroxin und Jodid im Vergleich zum Monopräparat Monothyroxin. Med Klin 1998;93:401-6.
16. Hotze A, Bockisch A, Horst M, et al. Vergleich der Wirksamkeit von reinem Levo-Thyroxin und einem Levo-Thyroxin-Jodid-Kombinationspräparat in der Therapie der blanden Struma. Nue Compact 1988;19:154-9.
17. Fish L, Schwartz H, Cavanaugh J, et al. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med 1987;316:764-70.
18. Hennessey JV, Burman KD, Wartofsky L. The equivalency of two L-thyroxine preparations. Ann Intern Med 1985;102:770-3.
19. Sawin CT, Surks MI, London M, et al. Oral thyroxine: variation in biologic action and tablet content. Ann Intern Med 1984;100:641-5.
20. Wenzel K, Mehrlander U. Wirksamkeitsunterschiede von Levothyroxin- Präparaten. Dtsch Med Wochenschr 1987;113:53-8.